Chinese Biotech Expects Limited Impact From SVB Aftermath
Financing Decoupling Already Underway
Executive Summary
Favored by venture capital funds, Silicon Valley Bank has served biotech firms conducting transactions in the US. But its collapse is generating a ripple effect on Chinese start-ups already hard hit by a funding crunch.